The panel discussion “Life Science Innovation: Who Should Pay?” was held May 9 at WBUR’s CitySpace. Hosted by Questrom’s Ravi K. Mehrotra Institute for Business, Markets, and Society, panelists Curt Nickisch (Questrom’13) (from right), Harvard Business Review IdeaCast cohost, U.S. Rep. Jake Auchincloss (D-Mass.), Rena Conti, a Questrom associate professor of markets, public policy, and law, Michael Sherman, RA Capital Management venture partner, and Andrew Obenshain, biotech company bluebird bio CEO, explored how to ensure continued innovation and access to gene and cell therapy without breaking the bank.